Anti-Mycobacterial Agents Flashcards
Treatment for rapidly growing tuberculosis with high bacillary load (cavitary)
Isoniazid
Treatment for spurters within the caseous material (caseous)
Rifampicin
Slow growing tuberculosis located intracellularly in macrophages and inflamed site
Pyrazinamide
Treatment for dormant tuberculous bacilli
Not susceptible
Symptoms of TB
chronic cough, fever, and weight loss
Drug with the strongest/most potent sterilizing activity that covers all subpopulations
Rifampicin
First line anti-TB drug that prevents relapse
Pyrazinamide
First line anti-TB drug that prevents resistance
Ethambutol
MOA of Rifampicin
RNA synthesis inhibitor
MOA of Isoniazid
Mycolic acid (Cell wall) synthesis inhibitor)
MOA of Pyrazinamide
Disruption of membrane energy metabolism
MOA of Ethambutol
Cell wall synthesis inhibition (Arabinoglycan)
DME inducer of the first line anti-TB drugs
Rifampicin
DME inhibitor of the first line anti-TB drugs
Isoniazid
Rifampicin’s adverse effect
Red orange secretions and urine
Isoniazid’s adverse effect
Peripheral neuritis
Pyrazinamide’s adverse effect
Hyperuricemia
Ethambutol’s adverse effect
Optic neuritis and impaired red-green color discrimination
Mechanism of resistance against Isoniazid
Mutation in Kat G and Inh A
First line drug used for latent TB infection; bactericidal after 24 hours
Isoniazid
Adverse effects of Isoniazid
Peripheral neuropathy (Vit B6 deficiency), Hepatitis, elevated ALT
Co-administration of this drug inactivates isoniazid
Vitamin C
Isoniazid increases toxicity of these drugs:
Phenytoin and Theophylline
Isoniazid increases its hepatotoxicity with:
Rifampicin and alcohol
Mechanism of resistance to Rifampicin
Mutation in rpo gene
Alternative to Isoniazid for latent TB infection, to Isoniazid resistant organisms, or to MOTT
Rifampicin